COVID-19 cases and hospitalizations are on the rise again ahead of the busy holiday travel season. Dr. Eric Cioe-Peña joins CBSN to discuss what this means for families planning to gather this ...
A third dose of the Pfizer vaccine is currently authorized for Americans who received their second dose at least six months ago and are ages 65 and older, have a job that increases their risk of ...
Health experts are reinforcing the point that full vaccination remains highly effective against severe illness and death caused by COVID-19 as federal regulators consider the possibility of ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia, according to a recent study.
Novavax on Wednesday received Food and Drug Administration authorization for a booster dose of its COVID-19 vaccine. Yet unlike the bivalent mRNA vaccines currently on the market, Novavax’s booster ...
The U.S. Food and Drug Administration has authorized booster shots of the Moderna and Pfizer COVID-19 vaccines for all adults ages 18 and older. On Friday, the FDA announced it had amended the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results